Metabolic syndrome in family medicine;Metabolički sindrom u obiteljskoj medicini

Acta Medica Croatica

Volumn 61, Issue 3, 2007, Pages 245-251

  Marković, Biserka Bergman ^a,d   Kern, Josipa ^a,b   Milaković, Sanja Blažeković ^a   Kranjcevic K ^c,e   Matijasevic I ^c,e   Repalust, Nevenka Winter ^a   Katic, Milica ^a   Jelinić, Jagoda Doko ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Ordinacija Op e Medicine   (Croatia)

^d University of Zagreb ^*  (Croatia)

^e Zagrebzapad Health Care Center   (Croatia)

Author keywords

Family medicine; Metabolic syndrome; Patient records

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; AWARENESS; BODY MASS; CHILD; CROATIA; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; FAMILY MEDICINE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; NEWBORN; PREVALENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; CARDIOVASCULAR DISEASE; GENERAL PRACTICE; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CROATIA; FAMILY PRACTICE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 34347225604     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106: 3143-421.
2. Sarafidis PA, Nilsson PM. The metabolic syndrome: a glanceat its history. J Hypertension 2006; 24: 621-6.
3. Reaven GM. Banting lecture 1988: role of insulin resistence in human disease. Diabetes 1988; 37: 1595-607.
4. Katzmaryk FT, Janssen I, Ross R, Church T. S, Blair SN. The importance of waist circumference in the definition of metabolic syndrome. Diabetes 2006; 29: 404-9.
5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes. Diabetes Care 2004 (Suppl. 1); 27: S5-S14.
6. McNeill AM, Rosamond WD, Girman CJ i sur. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerotic risk in communities study. Diabetes Care. 2005; 28: 385-90.
7. World Health Organisation. Definition, diagnosis and clasification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999. Dostupno na URL adresi: http//who.intriq/1999/ WHO_NCD_NCS_99.2pdf. Datum pristupa 15. travanj, 2006.
8. Vidal J, Moringo R, Codoceo VH, Casamitijana R, Pellitero S, Gomis R. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subject. Int J Obes 2005; 29: 668-74.
9. International Diabetes Federation (IDF): The IDF consensus worldwide definition of the metabolic syndrome. Dostupno na URL adresi: http://www.idf.org/ webdata/docs/. Datum pristupa 15. travanj, 2006.
10. Bergovec M, Miličić D, Reiner Ž, Mihatov Š. Čimbenici rizika za ishemijsku bolest srca u različitim dijelovima Hrvatske-LIBS V. Lijec Vjesn 2005; 127: 40.
11. Jelaković B, Kuzmanić D, Rončević T, Boršo G, Laganović M, Vdović M. Epidemiology of hypertension in Croatia. J Hypertension 2004; 22: 92.
12. National Institute of Neurological and Communicative Disorders and Stroke: The National Survey of Stroke. Stroke 1981; 2: 1-19.
13. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor find:ngs in the US population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med 2003; 163: 427-36.
14. Magi L, Stramenga C, Morosini P; Gruppo di Sudio SIMAP. Prevalence of the metabolic syndrome among Italian adults. Findings from SIMP study. Recenti Prog Med 2005 96: 280-3.
15. Ozsahin AK, Gokcel A, Sezgin N i sur. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 2004; 17: 230-4.
16. Alegria E, Cordero A, Laclaustra M i sur. Investigadores del registro MESYAS. Rev Esp Cardiol 2005; 58: 768-71.
17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
18. Azizi F, Salehi P, Etemadi A, Zahedi-Asl. Prevalence of metabolic syndrome in an urban population: Teheran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29-37.
19. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 4206-10.
20. Wilson PWF, Grundy SM. The metabolic syndrome-practical guide to origins and treatment: Part I. Circulation 2003; 108: 1422-5.
21. Stratton Im, Adler AI, Neil HA i sur. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observatinal study. BMJ 2000; 321: 405-12.
22. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors. Results from the Baltimore longitudinal study on aging. Diebetes 2004; 53: 2095-100.
23. Fox CS, Coady S, Sorlie PD i sur. Trends in cardiovascular complications of diabetes. JAMA 2004; 292: 2495-99.
24. Calle-Pascual AL, Saavedra A, Benedi A i sur. Changes in nutritional pattern, insulin sensitivity and glucose tolerance during weight loss in obese patients from a Mediterranean area. Hormone Metabol Res 1995; 27: 499-502.
25. Zieve FJ. The metabolic syndrome: diagnosis and treatment. Int J Obes (Lond) 2005; 29: 668-74.